Clinigen acquisition of Quantum Pharma approved
Updated : 16:49
Clinigen's acquisition of AIM peer Quantum Pharma, a manufacturer and supplier of unlicensed medicines and special obtain products, was approved on Tuesday.
Cancellation of trading of the Quantum shares on AIM will take place on 2 November.